Achondroplasia Treatment Market is Estimated to Witness High Growth Owing to promising product pipeline and rising awareness

 

Achondroplasia Treatment Market

Achondroplasia is the most common type of dwarfism. It results in an abnormal bone growth and disproportionately shorter arms and legs, as well as distinctive facial features such as an enlarged head and protruding forehead. The Achondroplasia Treatment includes recombinant human growth hormone, gene therapy, and bone lengthening surgery, which can help to increase height in people with achondroplasia. The treatment options address the underlying genetic defect and provide improved mobility and quality of life.

The global achondroplasia treatment market is estimated to be valued at US$127.8 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Promising product pipeline and growing awareness about treatment options are fuelling growth of the achondroplasia treatment market. Several pharmaceutical companies are developing pipeline candidates that target the underlying cause of achondroplasia rather than just managing symptoms. Some notable candidates in clinical trials include BioMarin's vosoritide, Ascendis Pharma's TransCon CNP and PhaseBio’s investigational product for achondroplasia. Moreover, support organizations like Achondroplasia Forward are raising awareness and advocacy efforts, which is positively impacting the market.

 Porter’s Analysis

Threat of new entrants: Low-moderate as this market requires huge R&D investments and regulatory approvals for treatment. Bargaining power of buyers: Moderate as limited options are available in the market. Bargaining power of suppliers: Moderate as suppliers have pricing power due to specialized drugs. Threat of new substitutes: Low as treatment options are limited. Competitive rivalry: High as key players are aggressively expanding their pipeline molecules.

SWOT Analysis

Strength: Existing treatment options, growing public awareness. Weakness: High cost of treatment, low diagnosis rates. Opportunity: Rising prevalence, emerging economies. Threats: Stringent regulations, reimbursement issues.

Key Takeaways

The Global Achondroplasia Treatment Market is expected to witness high growth, exhibiting CAGR of 12 % over the forecast period, due to increasing prevalence of Achondroplasia disorder globally.

The US market currently dominates the global Achondroplasia Treatment market and is expected to grow at a CAGR of over 35% during the forecast period, due to the strong presence of major pharmaceutical players, rising healthcare expenditure in the region. The Asia Pacific region is expected to be the fastest growing market exhibiting a CAGR of over 38% during the forecast period due to huge patient pool, rising geriatric population, and increasing medical tourism in countries like India, China and Japan.

Key players operating in the Achondroplasia Treatment market are BioMarin, RIBOMIC, Ascendis Pharma A/S, BridgeBio Pharma, Inc., Pfizer Inc., PhaseBio Pharmaceuticals, Inc., SiSaf, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, LG Chem, Ferring B.V., JCR Pharmaceuticals Co., Ltd, KVK TECH, INC., VIVUS LLC., ProLynx Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Ipsen Pharma, Novartis AG, and Xiamen Amoytop Biotech Co., Ltd. These players are focused on expanding their product portfolio by developing new and innovative therapies for more effective treatment of Achondroplasia through mergers, acquisitions and partnerships.

For more insights, Read- https://www.pressreleasebulletin.com/achondroplasia-treatment-market-demand-size-and-insights/

Comments

Post a Comment

Popular posts from this blog

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the ...
Read more

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million ...
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv...
Read more